BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37805344)

  • 1. The cell biology of APOE in the brain.
    Windham IA; Cohen S
    Trends Cell Biol; 2024 Apr; 34(4):338-348. PubMed ID: 37805344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol and matrisome pathways dysregulated in astrocytes and microglia.
    Tcw J; Qian L; Pipalia NH; Chao MJ; Liang SA; Shi Y; Jain BR; Bertelsen SE; Kapoor M; Marcora E; Sikora E; Andrews EJ; Martini AC; Karch CM; Head E; Holtzman DM; Zhang B; Wang M; Maxfield FR; Poon WW; Goate AM
    Cell; 2022 Jun; 185(13):2213-2233.e25. PubMed ID: 35750033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer's disease.
    Liu CC; Wang N; Chen Y; Inoue Y; Shue F; Ren Y; Wang M; Qiao W; Ikezu TC; Li Z; Zhao J; Martens Y; Doss SV; Rosenberg CL; Jeevaratnam S; Jia L; Raulin AC; Qi F; Zhu Y; Alnobani A; Knight J; Chen Y; Linares C; Kurti A; Fryer JD; Zhang B; Wu LJ; Kim BYS; Bu G
    Nat Immunol; 2023 Nov; 24(11):1854-1866. PubMed ID: 37857825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE traffics to astrocyte lipid droplets and modulates triglyceride saturation and droplet size.
    Windham IA; Powers AE; Ragusa JV; Wallace ED; Zanellati MC; Williams VH; Wagner CH; White KK; Cohen S
    J Cell Biol; 2024 Apr; 223(4):. PubMed ID: 38334983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types.
    Lin YT; Seo J; Gao F; Feldman HM; Wen HL; Penney J; Cam HP; Gjoneska E; Raja WK; Cheng J; Rueda R; Kritskiy O; Abdurrob F; Peng Z; Milo B; Yu CJ; Elmsaouri S; Dey D; Ko T; Yankner BA; Tsai LH
    Neuron; 2018 Jun; 98(6):1141-1154.e7. PubMed ID: 29861287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice.
    Ophir G; Meilin S; Efrati M; Chapman J; Karussis D; Roses A; Michaelson DM
    Neurobiol Dis; 2003 Feb; 12(1):56-64. PubMed ID: 12609489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes.
    Lee H; Cho S; Kim MJ; Park YJ; Cho E; Jo YS; Kim YS; Lee JY; Thoudam T; Woo SH; Lee SI; Jeon J; Lee YS; Suh BC; Yoon JH; Go Y; Lee IK; Seo J
    Cell Rep; 2023 Oct; 42(10):113183. PubMed ID: 37777962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E ε4 disrupts oligodendrocyte differentiation by interfering with astrocyte-derived lipid transport.
    Mok KK; Yeung SH; Cheng GW; Ma IW; Lee RH; Herrup K; Tse KH
    J Neurochem; 2023 Apr; 165(1):55-75. PubMed ID: 36549843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE and Alzheimer's disease: Pathologic clues from transgenic Drosophila melanogaster.
    Haddadi M; Haghi M; Rezaei N; Kiani Z; Akkülah T; Celik A
    Arch Gerontol Geriatr; 2024 Aug; 123():105420. PubMed ID: 38537387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.
    Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y
    J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoform- and cell-state-specific lipidation of ApoE in astrocytes.
    Lindner K; Beckenbauer K; van Ek LC; Titeca K; de Leeuw SM; Awwad K; Hanke F; Korepanova AV; Rybin V; van der Kam EL; Mohler EG; Tackenberg C; Lakics V; Gavin AC
    Cell Rep; 2022 Mar; 38(9):110435. PubMed ID: 35235798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
    Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
    Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist.
    Litvinchuk A; Suh JH; Guo JL; Lin K; Davis SS; Bien-Ly N; Tycksen E; Tabor GT; Remolina Serrano J; Manis M; Bao X; Lee C; Bosch M; Perez EJ; Yuede CM; Cashikar AG; Ulrich JD; Di Paolo G; Holtzman DM
    Neuron; 2024 Feb; 112(3):384-403.e8. PubMed ID: 37995685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.
    Butterfield DA; Mattson MP
    Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
    Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
    Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
    Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T
    Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease.
    Li Y; Macyczko JR; Liu CC; Bu G
    Neurobiol Aging; 2022 Jul; 115():20-28. PubMed ID: 35453035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncovering mechanisms of brain inflammation in Alzheimer's disease with APOE4: Application of single cell-type lipidomics.
    Asante I; Louie S; Yassine HN
    Ann N Y Acad Sci; 2022 Dec; 1518(1):84-105. PubMed ID: 36200578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease.
    Ayyubova G
    CNS Neurol Disord Drug Targets; 2024; 23(3):342-352. PubMed ID: 36872358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.